Cystinuria clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Lipoic Acid Supplement for Cystine Stone
Sorry, in progress, not accepting new patients
This study evaluates how daily alpha lipoic acid supplementation affects cystine kidney stone recurrence. Half of the subjects will receive 1200 mg alpha lipoic acid orally daily for three years, while the other half will receive a placebo. The funding source for this clinical trial is FDA OOPD.
at UCSF